A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

NCT01100801 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Gastric Cancer

Interventions

DRUG: TS-1 with cisplatin
DRUG: TS-1 with oxaliplatin

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]
[object Object]